These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34686532)

  • 1. Correspondence on "European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery" by Fotopoulou et al.
    Chandra R; Ray M
    Int J Gynecol Cancer; 2021 Dec; 31(12):1618. PubMed ID: 34686532
    [No Abstract]   [Full Text] [Related]  

  • 2. Upper abdominal debulking surgery for ovarian cancer total colectomy, total peritonectomy, and extended upper abdominal debulking surgery.
    Taskiran C; Vatansever D; Giray B; Eraslan A; Tanju S; Arvas M; Balik E
    Int J Gynecol Cancer; 2020 Oct; 30(10):1648-1649. PubMed ID: 32948641
    [No Abstract]   [Full Text] [Related]  

  • 3. A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcome.
    Manning-Geist BL; Hicks-Courant K; Gockley AA; Clark RM; Del Carmen MG; Growdon WB; Horowitz NS; Berkowitz RS; Muto MG; Worley MJ
    Am J Obstet Gynecol; 2019 Oct; 221(4):326.e1-326.e7. PubMed ID: 31082382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival outcomes after delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer.
    Yao SE; Tripcony L; Sanday K; Robertson J; Perrin L; Chetty N; Land R; Garrett A; Obermair A; Nascimento M; Tang A; Jagasia N; Singh P; Nicklin J
    Int J Gynecol Cancer; 2020 Dec; 30(12):1935-1942. PubMed ID: 33122245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing feasibility and perioperative outcomes with minimally invasive surgery compared with laparotomy for interval debulking surgery with hyperthermic intraperitoneal chemotherapy for advanced epithelial ovarian cancer.
    Morton M; Chambers LM; Costales AB; Chichura A; Gruner M; Horowitz MP; Rose PG; Yao M; Debernardo R; Michener C
    Gynecol Oncol; 2021 Jan; 160(1):45-50. PubMed ID: 33067001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery.
    Fotopoulou C; Planchamp F; Aytulu T; Chiva L; Cina A; Ergönül Ö; Fagotti A; Haidopoulos D; Hasenburg A; Hughes C; Knapp P; Morice P; Schneider S; Sehouli J; Stamatakis E; Suria S; Taskiran C; Trappe RU; Campbell J
    Int J Gynecol Cancer; 2021 Sep; 31(9):1199-1206. PubMed ID: 34407962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal residual disease at primary debulking surgery versus complete tumor resection at interval debulking surgery in advanced epithelial ovarian cancer: A survival analysis.
    Ghirardi V; Moruzzi MC; Bizzarri N; Vargiu V; D'Indinosante M; Garganese G; Pasciuto T; Loverro M; Scambia G; Fagotti A
    Gynecol Oncol; 2020 Apr; 157(1):209-213. PubMed ID: 31952843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporating robotic surgery into the management of ovarian cancer after neoadjuvant chemotherapy.
    Abitbol J; Gotlieb W; Zeng Z; Ramanakumar A; Kessous R; Kogan L; Pare-Miron V; Rombaldi M; Salvador S; Kucukyazici B; Brin S; How J; Lau S
    Int J Gynecol Cancer; 2019 Nov; 29(9):1341-1347. PubMed ID: 31601648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robotic interval debulking surgery for advanced epithelial ovarian cancer: current challenge or future direction? A systematic review.
    Psomiadou V; Prodromidou A; Fotiou A; Lekka S; Iavazzo C
    J Robot Surg; 2021 Apr; 15(2):155-163. PubMed ID: 33037532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When Less Is More: Minimally Invasive Surgery Compared with Laparotomy for Interval Debulking After Neoadjuvant Chemotherapy in Women with Advanced Ovarian Cancer.
    Brown J; Drury L; Crane EK; Anderson WE; Tait DL; Higgins RV; Naumann RW
    J Minim Invasive Gynecol; 2019; 26(5):902-909. PubMed ID: 30240899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of hospital surgical volume on complete gross resection (CGR) rates following primary debulking surgery for advanced stage epithelial ovarian carcinoma.
    Nasioudis D; Kahn R; Chapman-Davis E; Frey MK; Caputo TA; Witkin SS; Holcomb K
    Gynecol Oncol; 2019 Aug; 154(2):401-404. PubMed ID: 31160074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and outcomes after bowel surgery and ostomy formation at the time of debulking surgery for advanced-stage epithelial ovarian carcinoma.
    Gockley AA; Fiascone S; Hicks Courant K; Pepin K; Del Carmen M; Clark RM; Goldberg J; Horowitz N; Berkowitz R; Worley M
    Int J Gynecol Cancer; 2019 Mar; 29(3):585-592. PubMed ID: 30833444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European Society of Gynaecological Oncology (ESGO) Guidelines for Ovarian Cancer Surgery.
    Querleu D; Planchamp F; Chiva L; Fotopoulou C; Barton D; Cibula D; Aletti G; Carinelli S; Creutzberg C; Davidson B; Harter P; Lundvall L; Marth C; Morice P; Rafii A; Ray-Coquard I; Rockall A; Sessa C; van der Zee A; Vergote I; duBois A
    Int J Gynecol Cancer; 2017 Sep; 27(7):1534-1542. PubMed ID: 30814245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progress in preoperative evaluation methods regarding cytoreduction in patients with advanced ovarian cancer].
    Liu J; Zhang K
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Jul; 42(7):854-859. PubMed ID: 28845013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the role of surgery in the management of advanced epithelial ovarian cancer.
    Straubhar A; Chi DS; Long Roche K
    Clin Adv Hematol Oncol; 2020 Nov; 18(11):723-731. PubMed ID: 33406064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-operative prediction of residual disease after interval cytoreduction for epithelial ovarian cancer using HE4.
    Lof P; van de Vrie R; Korse CM; van Driel WJ; van Gent MDJM; Karlsen MA; Amant F; Lok CAR
    Int J Gynecol Cancer; 2019 Oct; 29(8):1304-1310. PubMed ID: 31515411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compliance to treatment guidelines and survival in women undergoing interval debulking surgery for advanced epithelial ovarian cancer.
    Shylasree TS; Kattepur AK; Gupta M; Ghosh J; Maheshwari A; Bajpai J; Hawaldar R; Gulia S; Deodhar K; Popat P; Gupta S; Kerkar RA
    Cancer Rep (Hoboken); 2020 Apr; 3(2):e1217. PubMed ID: 32671995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of morbidity associated with pancreatic resection during cytoreductive surgery for epithelial ovarian cancer: A systematic review.
    Di Donato V; Bardhi E; Tramontano L; Capomacchia FM; Palaia I; Perniola G; Plotti F; Angioli R; Giancotti A; Muzii L; Panici PB
    Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):694-702. PubMed ID: 31806515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multivariate analysis of the prognostic impact of tumor burden, surgical timing and complexity after complete cytoreduction for advanced ovarian cancer.
    Angeles MA; Rychlik A; Cabarrou B; Spagnolo E; Guyon F; Pérez-Benavente A; Gil-Moreno A; Siegrist J; Querleu D; Mery E; Gladieff L; Hernández A; Ferron G; Martinez A
    Gynecol Oncol; 2020 Sep; 158(3):614-621. PubMed ID: 32709536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correspondence on "Quality is more important than quantity: pre-operative sarcopenia is associated with poor survival in advanced ovarian cancer" by Polen-De et al.
    Maccio A; Madeddu C
    Int J Gynecol Cancer; 2022 Nov; 32(11):1493. PubMed ID: 36253005
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.